When was avte $24 a share


Aime
The price of $24 per share for Aerovate Therapeutics (AVTE) has not been achieved in the recent past. Here's the analysis:
- Current Stock Price: The most recent data shows that the closing price for AVTE was $24.62 on June 14, 20241.
- Historical Prices: Looking at historical prices, the highest closing price in the past year was $32.42, which occurred on December 7, 20232. The lowest closing price was $9.41, on January 4, 20242.
- Insider Transactions: It's important to note that the Chief Medical Officer (CMO), Hunter Gillies, sold 6,000 shares at $24.50 per share on June 13, 20243, and the Chief Technical Officer (CTO), Marinus Verwijs, sold 10,600 shares at $25.00 per share on June 14, 20244. These transactions were part of pre-arranged trading plans, which suggest that they were not based on material, non-public information.
- Market Dynamics: The stock's day high on June 13, 2024, was $24.77, and the day low was $22.511. This indicates that the stock was trading in a range on that day, and a price of $24 per share was not reached.
- Future Prospects: Aerovate Therapeutics is expecting topline data from the Phase 2b portion of the IMPAHCT trial in June 20245, which could have an impact on the stock price. However, past performance and insider transactions do not indicate a specific price target of $24 per share in the near future.
In conclusion, while the current stock price is close to $24, the exact price of $24 per share for AVTE has not been realized in the recent past, and it is not supported by historical data or insider transactions.
Source:
i
1.
Historical Price Lookup
more
less
Continue this conversation 

Explore
Screener
Analysis
Wiki